Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02154061Completed
Randomised, open-label trial of Fluzone Trivalent in influenza (2 arms), sponsored by Emory University. Primary endpoint: Participants With Four Fold Rise in HAI Titers or HAI 1:40 and Above at 30 days. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02154061.